06628 TRANSCENTA-B
Trading Add to Porfolio| Index Constituent : None | |||
| Major Shareholders | Shi Yi (16.22%) Xueming Qian & Family (6.81%) Temasek Holdings (Private) Limited (6.46%) China Structural Reform Fund Corporation Limited (6.22%) Shi Xiaohong (5.15%) |
Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | http://www.transcenta.com/ | Tel | (86 21) 6237-0929 |
| ir@transcenta.com | Fax | N/A | |
| Related Equities | N/A | ||
| Principal Activities | The Company is an integrated biopharma platform that brings drug candidates from the discovery stage to the commercial stage, spanning discovery, research, development, manufacturing and commercialization. | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
